<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>GLP-1 weight loss drugs may be misused by patients with eating disorders: Study — Live Feed</title><link>https://www.live-feeds.com/feed/glp-1-weight-loss-drugs-may-be-misused-by-patients-with-eating-disorders-study</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/glp-1-weight-loss-drugs-may-be-misused-by-patients-with-eating-disorders-study/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Study Links GLP-1 Weight Loss Drug Misuse to Eating Disorders</title><link>https://www.live-feeds.com/feed/glp-1-weight-loss-drugs-may-be-misused-by-patients-with-eating-disorders-study</link><guid isPermaLink="false">https://www.live-feeds.com/feed/glp-1-weight-loss-drugs-may-be-misused-by-patients-with-eating-disorders-study#u20764</guid><pubDate>Thu, 02 Jul 2026 00:56:29 +0000</pubDate><description>A JAMA Psychiatry study indicates that individuals with eating disorders may misuse GLP-1 receptor agonists like Ozempic and Wegovy. These patients reported using weight loss injections at more than twice the rate of the general population. The research suggests these drugs may be used to sustain eating disorders.What's confirmed:A study in JAMA Psychiatry found that people with eating disorders report using GLP-1 drugs at more than twice the rate of the general population.Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.GLP-</description></item>
</channel></rss>